Cargando…

Activated ALK signals through the ERK–ETV5–RET pathway to drive neuroblastoma oncogenesis

Activating mutations of the ALK receptor occur in a subset of neuroblastoma tumors. We previously demonstrated that Alk mutations cooperate with MYCN overexpression to induce neuroblastoma in mice and identified Ret as being strongly upregulated in MYCN/Alk(mut) tumors. By a genetic approach in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Delisle, Lucille, Pierre-Eugène, Cécile, Louis-Brennetot, Caroline, Surdez, Didier, Raynal, Virginie, Baulande, Sylvain, Boeva, Valentina, Grossetête-Lalami, Sandrine, Combaret, Valérie, Peuchmaur, Michel, Delattre, Olivier, Janoueix-Lerosey, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168456/ https://www.ncbi.nlm.nih.gov/pubmed/29321660 http://dx.doi.org/10.1038/s41388-017-0039-5

Ejemplares similares

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
por: Cazes, Alex, et al.
Publicado: (2014)

ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations
por: Durand, Simon, et al.
Publicado: (2019)

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020)

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma
por: Bellini, Angela, et al.
Publicado: (2019)

Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis
por: Boeva, Valentina, et al.
Publicado: (2013)

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
por: Thirant, Cécile, et al.
Publicado: (2023)

BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells
por: Sriha, Jessica, et al.
Publicado: (2022)

HMCan-diff: a method to detect changes in histone modifications in cells with different genetic characteristics
por: Ashoor, Haitham, et al.
Publicado: (2017)

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
por: Costa, Ana, et al.
Publicado: (2022)

Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells
por: Montavon, Gisèle, et al.
Publicado: (2014)

Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
por: Gautier, Margot, et al.
Publicado: (2021)

Hyperactivation of Alk induces neonatal lethality in knock-in Alk(F1178L) mice
por: Lopez-Delisle, Lucille, et al.
Publicado: (2014)

Internalization and Down-Regulation of the ALK Receptor in Neuroblastoma Cell Lines upon Monoclonal Antibodies Treatment
por: Mazot, Pierre, et al.
Publicado: (2012)

Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN
por: Guimier, Anne, et al.
Publicado: (2014)

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
por: Tucker, Elizabeth R., et al.
Publicado: (2023)

Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization
por: Boeva, Valentina, et al.
Publicado: (2011)

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
por: Brisse, Hervé J., et al.
Publicado: (2017)

Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis
por: Lu, Benson, et al.
Publicado: (2009)

SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data
por: Zeitouni, Bruno, et al.
Publicado: (2010)

Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data
por: Boeva, Valentina, et al.
Publicado: (2012)

Learning smoothing models of copy number profiles using breakpoint annotations
por: Hocking, Toby Dylan, et al.
Publicado: (2013)

SV-Bay: structural variant detection in cancer genomes using a Bayesian approach with correction for GC-content and read mappability
por: Iakovishina, Daria, et al.
Publicado: (2016)

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
por: Mus, Liselot M., et al.
Publicado: (2020)

Detection of tumor ALK status in neuroblastoma patients using peripheral blood
por: Combaret, Valérie, et al.
Publicado: (2015)

ETV1 is a lineage-specific survival factor in GIST and cooperates with KIT in oncogenesis
por: Chi, Ping, et al.
Publicado: (2010)

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction
por: Deveau, Paul, et al.
Publicado: (2018)

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2
por: Wagner, Simona M., et al.
Publicado: (2012)

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
por: Bellini, Angela, et al.
Publicado: (2021)

Ret and Etv4 Promote Directed Movements of Progenitor Cells during Renal Branching Morphogenesis
por: Riccio, Paul, et al.
Publicado: (2016)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

SegAnnDB: interactive Web-based genomic segmentation
por: Hocking, Toby D., et al.
Publicado: (2014)

Correction: Ret and Etv4 Promote Directed Movements of Progenitor Cells during Renal Branching Morphogenesis
Publicado: (2016)

Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
por: Siaw, Joachim T., et al.
Publicado: (2021)

De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysis
por: Boeva, Valentina, et al.
Publicado: (2010)

Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on‐target ALK inhibitors in neuroblastoma
por: Tucker, Elizabeth R., et al.
Publicado: (2017)

ALK in Neuroblastoma: Biological and Therapeutic Implications
por: Trigg, Ricky M., et al.
Publicado: (2018)

The role of the ShcD and RET interaction in neuroblastoma survival and migration
por: Mabruk, Zeanap A., et al.
Publicado: (2018)

Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma
por: Ram Kumar, Ram Mohan, et al.
Publicado: (2018)

Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples()()
por: Zhao, Chao, et al.
Publicado: (2014)

MYCN and mutationally activated ALK synergise in neuroblastoma
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d5h639adlu6t7lp95c99a19lr3